newsfilter
← Latest News
GlobeNewswire·

Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan

SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight® Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision